RS53996B1 - Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors - Google Patents

Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors

Info

Publication number
RS53996B1
RS53996B1 RS20150240A RSP20150240A RS53996B1 RS 53996 B1 RS53996 B1 RS 53996B1 RS 20150240 A RS20150240 A RS 20150240A RS P20150240 A RSP20150240 A RS P20150240A RS 53996 B1 RS53996 B1 RS 53996B1
Authority
RS
Serbia
Prior art keywords
core
prophylaxis
tumors
compositions
treatment
Prior art date
Application number
RS20150240A
Other languages
Serbian (sr)
Inventor
Steffen Goletz
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Priority claimed from EP06090208.7A external-priority patent/EP1920781B1/en
Publication of RS53996B1 publication Critical patent/RS53996B1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Formulacija koja je izabrana iz grupe koja se sastoji od nutraceutske i/ili farmaceutske kompozicije, koja sadrži najmanje jedan Core-1 pozitivni mikroorganizam, koji je izabran iz grupe koja se sastoji od DSM 18726 (AG6) i DSM 18728 (MU1), i/ili najmanje jednog njihovog lizata ili frakcije, koji sadrži najmanje jednu Core-1 pozitivnu komponentu.Prijava sadrži još 10 patentnih zahteva.A formulation selected from the group consisting of a nutraceutical and / or pharmaceutical composition comprising at least one Core-1 positive microorganism, selected from the group consisting of DSM 18726 (AG6) and DSM 18728 (MU1), and / or at least one of their lysates or fractions containing at least one Core-1 positive component. The application contains 10 more claims.

RS20150240A 2006-11-10 2006-11-10 Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors RS53996B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06090208.7A EP1920781B1 (en) 2006-11-10 2006-11-10 Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors

Publications (1)

Publication Number Publication Date
RS53996B1 true RS53996B1 (en) 2015-10-30

Family

ID=41421508

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150240A RS53996B1 (en) 2006-11-10 2006-11-10 Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors

Country Status (9)

Country Link
CN (1) CN101600454A (en)
CY (1) CY1116319T1 (en)
DK (1) DK1920781T3 (en)
ES (1) ES2533965T3 (en)
HR (1) HRP20150363T1 (en)
PT (1) PT1920781E (en)
RS (1) RS53996B1 (en)
SI (1) SI1920781T1 (en)
UA (1) UA103153C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2893170T3 (en) * 2011-08-22 2022-02-08 Te Bios Co Ltd Microorganisms of the species Bacteroides xylanisolvens DSM23964 (CTC1) and their use for the production of a food
SG11201406022YA (en) * 2012-03-27 2014-10-30 Abbott Lab Methods for modulating cell-mediated immunity using human milk oligosaccharides
CN103320363B (en) * 2013-07-03 2015-02-18 广州中国科学院先进技术研究所 Culture medium used for separating and screening lactic acid bacteria, preparation method and application thereof
CN111323283B (en) * 2020-04-20 2021-06-25 厦门大学 Method for enriching N-phosphorylated protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374755B2 (en) * 2004-07-26 2008-05-20 The Research Foundation Of State University Of New York Therapeutic use of anti-TF-Antigen antibody

Also Published As

Publication number Publication date
ES2533965T3 (en) 2015-04-16
UA103153C2 (en) 2013-09-25
DK1920781T3 (en) 2015-04-20
CY1116319T1 (en) 2017-02-08
CN101600454A (en) 2009-12-09
HRP20150363T1 (en) 2015-07-31
SI1920781T1 (en) 2015-07-31
PT1920781E (en) 2015-05-18

Similar Documents

Publication Publication Date Title
RS51563B (en) Pharmaceutical compositions containing rosuvastatin calcium
UY30030A1 (en) SUBSTITUTED DERIVATIVES OF 8-PIRACIN-2-IL-1,2,4,4A-TETRAHIDRO-2´H, 6H-ESPIRO (1,4-OXACIN (4,3-A) QUINOLIN-5,5´-PIRIMIDIN ) -2´, 4´, 6´ (1´H, 3´H) -TIONA, COMPOSITIONS AND APPLICATIONS
BRPI0509074A (en) pharmaceutical compositions comprising thyroid receptor agonists
AU2001278003A1 (en) Bacteriophage having multiple host range
UY31209A1 (en) USE OF HOMO AND COPOLIMEROS FOR THE STABILIZATION OF FORMULATIONS OF ACTIVE PRINCIPLES
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
PL359419A1 (en) Glycopeptide phosphonate derivatives
NI201000055A (en) 2 '- FLUORO - 2' - DEOXYTETHYDROURIDINES AS INHIBITORS OF CITIDINE DESAMINE.
HUS1800013I1 (en) Oral formulations of cladribine
BRPI0715579A2 (en) "compound, pharmaceutical composition and use of a compound"
BRPI0809977A8 (en) USE OF A COMPOUND, COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING IT
MX2009004714A (en) 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators.
ECSP045004A (en) INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF DEPENDING ANDROGEN DISEASES
MX2009005011A (en) Imidazopyrazines as protein kinase inhibitors.
UA100190C2 (en) Akt and p70 s6 kinase inhibitors
TW200619848A (en) Photoresist compositions
BRPI0507186A (en) composition, methods and uses for a new family of peptides
CR20220014A (en) 3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents
GEP20217266B (en) CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
SI1539114T1 (en) Film coating for tablets and caplets
RS53996B1 (en) Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors
MX2021014680A (en) Benzotriazole derivative.
JOP20220093A1 (en) Pharmaceutical composition comprising selexipag
CL2008003602A1 (en) Compounds derived from triazolotriazines and substituted triazolopyrazines; pharmaceutical composition; and its use in the treatment and / or prophylaxis of hematological disorders.
EP2125831A4 (en) Oxazinyl isoflavonoid compounds, medicaments and use